Skip to main content
Sign In
 

Mary P. Glodé, MD

Professor of Pediatrics


 

Section Head, Infectious Diseases

Contact
   Phone: 720-777-1234 (TBD)
   E-mail: (TBD)

Affiliations
Section of Infectious Diseases, Department of Pediatrics
Section of Epidemiology, Department of Pediatrics
Children's Hospital Colorado

Certifications
Pediatrics, Pediatric Infectious Diseases

Mary P. Glodé, MD, earned her medical degree from Washington University School of Medicine in 1972. Following residency training at the University of Texas Southwestern Medical School, she completed a postdoctoral fellowship at the National Institutes of Health in 1976 and a fellowship in pediatric and adult infectious diseases at Harvard Medical School in 1978.

Dr. Glodé joined the faculty of the Department of Pediatrics at the University of Colorado School of Medicine and Children’s Hospital Colorado in 1978. In addition to directing the Pediatric Residency Program for more than 10 years and serving as Vice Chair of Education for the Department of Pediatrics for 14 years, Dr. Glodé has served as Section Head of Infectious Diseases since 2002. She was named a Career Teaching Scholar by the Department of Pediatrics in 2003.

Internationally recognized as an expert on Kawasaki disease and immunization, Dr. Glodé frequently presents at local, national, and international conferences. She is involved in clinical vaccine trials and pursues clinical studies of the etiology, epidemiology, and therapy of Kawasaki disease. She has published over 150 journal articles, abstracts, and book chapters on pediatric infectious diseases. Dr. Glodé has participated in numerous national advisory committees for the Food and Drug Administration, the Centers for Disease Control and Prevention, and the National Institutes of Health. Her major areas of scientific interest include Kawasaki disease, the development of new pediatric vaccines, and residency education.

  • Best Doctors in America, 2008-present
  • 5280 Magazine's Top Doctors in Denver, 2005-present
  • Red Book Committee on Infectious Disease, AAP, 2007-2011
  • Quality and Safety Pillar Award, Children's Hospital Colorado, 2010
  • Invited Speaker, International Kawasaki Symposium, 2008
  • Special Recognition Award, Dedication and Service to Recruitment, Department of Pediatrics, UCSOM, 2007
  • Charles C. Shepard Science Award, Scientific Excellence demonstrated by the publication of the Pneumococcal Vaccine Study in the Lancet, CDC, 2007
  • FDA Advisory Committee on Pediatric Drugs, 2004-2005
  • FDA Advisory Committee on Anti-Infectives, 2001-2004
  • Career Teaching Scholar Award, Department of Pediatrics, University of Colorado School of Medicine, 2003

Publications in PubMed

  • Dominguez SR, Briese T, Palacios G, Renwick N, Hui J, Villari J, Kapoor V, Drysdale A, Glodé MP, Anderson MS, Robinson CC, Holmes KV, Lipkin WI. Multiplex Mass Tag- PCR for respiratory pathogens in pediatric nasopharyngeal washes negative by conventional diagnostic testing shows a high prevalence of viruses belonging to a newly-recognized rhinovirus clade. J Clin Virol. 2008;43(2):219-22. [PMID: 18674964]
  • Dominguez SR, Friedman K, Seewald R, Anderson MS, Willis L, Glodé MP. Kawasaki disease in a pediatric intensive care unit: a case control study. 2008;122(4):e786-90. [PMID: 18809597]
  • Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, Oberste MS, Glodé MP. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007 Oct;45(8):950-7. [PMID: 17879907]
  • Perez-Velez C, Anderson M, Glodé M, McFarland E, Nix W, Oberste M, Pallansch M, Robinson C. Outbreak of poliomyelitis-like paralytic enterovirus 71 disease in Colorado. Clin Infect Dis. 2007;45:950-7.
  • Dominguez SR, Anderson M, Glodé MP, Robinson C, Holmes KV. Lack of association between infection with human coronavirus NL63/NH and Kawasaki Syndrome. J Infect Dis. 2006 Dec;194(12):1697-701.
  • Dominguez SR, Anderson MS, Glodé MP, Robinson CC, Holmes KV. Blinded case-control study of the relationship between human coronavirus NL63 and Kawasaki syndrome. J Infect Dis. 2006 Dec;194(12):1697-701. [PMID: 17109341]
  • Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glodé MP, Zell ER, Jorgensen JH, Beall B, Schuchat A. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet. 2006 Oct;368(9546):1495-502. [PMID: 17071283]
  • Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, Glode MP, Ehresmann KR. Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001. Pediatrics. 2005 Aug;116(2):e285-94. [PMID: 16061582]
  • Anderson MS, Todd JK, Glode MP. Delayed diagnosis of Kawasaki syndrome: an analysis of the problem. Pediatrics. 2005 Apr;115(4):e428-33. [PMID: 15805345]
  • De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR. Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J. 2005 Mar;24(3):278-80. [PMID: 15750472]